Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
784
-
Total 13F shares, excl. options
-
93.6M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$51.2B
-
Value change
-
-$500M
-
Put/Call ratio
-
0.84
-
Number of buys
-
378
-
Number of sells
-
-307
-
Price
-
$546.86
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2021
875 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2021.
DEXCOM INC - Common Stock (DXCM) has 784 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.6M shares
of 392M outstanding shares and own 23.87% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.3M shares), BlackRock Inc. (7.63M shares), BAILLIE GIFFORD & CO (5.35M shares), FMR LLC (4.55M shares), STATE STREET CORP (3.91M shares), SANDS CAPITAL MANAGEMENT, LLC (3.32M shares), JPMORGAN CHASE & CO (2.99M shares), JANUS HENDERSON GROUP PLC (2.62M shares), Nuveen Asset Management, LLC (2.1M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.79M shares).
This table shows the top 784 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.